title: Chronic Migraine with Medication Overuse and OnabotulinumtoxinA: Two Positive Case Reports of a Modified Injection Protocol.
authors.affiliation: Department of Clinical and Experimental Medicine, University of Pisa, Italy.
authors.forename: Sonia
authors.initials: S
authors.lastname: Mazzucchi
authors.affiliation: Department of Clinical and Experimental Medicine, University of Pisa, Italy.
authors.forename: Martina
authors.initials: M
authors.lastname: Cafalli
authors.affiliation: Department of Clinical and Experimental Medicine, University of Pisa, Italy.
authors.forename: Filippo
authors.initials: F
authors.lastname: Baldacci
authors.affiliation: Department of Clinical and Experimental Medicine, University of Pisa, Italy.
authors.forename: Cinzia
authors.initials: C
authors.lastname: Lucchesi
authors.affiliation: Department of Clinical and Experimental Medicine, University of Pisa, Italy.
authors.forename: Ubaldo
authors.initials: U
authors.lastname: Bonuccelli
authors.affiliation: Department of Clinical and Experimental Medicine, University of Pisa, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Gori
mesh_terms: D065087:Acetylcholine Release Inhibitors / Q000009:adverse effects*; D019274:Botulinum Toxins, Type A / Q000009:adverse effects*; D002908:Chronic Disease; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D000067490:Prescription Drug Overuse
chemical_list: D065087:Acetylcholine Release Inhibitors; D019274:Botulinum Toxins, Type A
keywords: OnabotulinumtoxinA; chronic migraine; photophobia